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Metabolic regulation and the anti-obesity perspectives of human brown fat
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A B S T R A C T
Activation of brown adipose tissue (BAT) in adult humans increase glucose and fatty acid clearance as well as
resting metabolic rate, whereas a prolonged elevation of BAT activity improves insulin sensitivity. However,
substantial reductions in body weight following BAT activation has not yet been shown in humans. This
observation raise the possibility for feedback mechanisms in adult humans in terms of a brown fat-brain
crosstalk, possibly mediated by batokines, factors produced by and secreted from brown fat. Batokines also
seems to be involved in BAT recruitment by stimulating proliferation and diﬀerentiation of brown fat
progenitors. Increasing human BAT capacity could thus include inducing brown fat biogenesis as well as
identifying novel batokines. Another attractive approach would be to induce a brown fat phenotype, the so-
called brite or beige fat, within the white fat depots. In adult humans, white fat tissue transformation into beige
has been observed in patients with pheochromocytoma, a norepinephrine-producing tumor. Interestingly,
human beige fat is predominantly induced in regions that were BAT during early childhood, possibly reﬂecting
that a presence of human beige progenitors is depot speciﬁc and originating from BAT. In conclusion, to utilize
the anti-obesity potential of human BAT focus should be directed towards identifying novel regulators of brown
and beige fat progenitor cells, as well as feedback mechanisms of BAT activation. This would allow for
identiﬁcation of novel anti-obesity targets.
1. Introduction
The discovery of substantial amounts of active brown fat being
present in adult humans [1–5] has raised the expectations for the
development of new anti-obesity treatments by targeting this tissue.
Brown fat consumes energy by activation of non-shivering thermogen-
esis through sympathetic signalling [6]. In adult humans, brown fat has
been veriﬁed at a molecular level in the supraclavicular region [7,8],
deep neck [9] and in the perirenal region [10]. From initial PET/CT
images, it is clear that active brown fat is also present around the spinal
cord in the intercostal regions [1–5]. This review will focus on human
brown fat, however, as brown fat has been studied in rodents for
decades, some comparison on key concepts will be provided when
considered relevant. In rodents, the association between obesity and
reduced brown fat activity is well-established [11] and a sympathetic
denervation of intrascapular BAT was demonstrated to mediate an
increase in body fat [12]. In humans, however, the eﬃciency of BAT
activation as an anti-obesity strategy could be questioned, as the
amount of BAT in relation to whole body mass, is substantially lower
than in rodents [13]. The diﬀerences in the eﬀects of BAT activation
between mice and humans might also include a more complex
regulatory network for preserving energy balance and individual body
weight set-point present in humans. For example, secreted factors
derived from activated brown fat, called batokines [14] should be
further explored for their potential role in regulating BAT activity and
its eﬀects on whole body metabolism. In this review, we aim to provide
an overview of what is known to date about the plasticity of human
brown fat abundancy and frequency and its role in adult human
metabolism. This overview could serve as a basis for discussing
potential strategies for using brown fat in the development of novel
treatments against obesity.
2. Sympathetic activation of human brown fat mitochondria
In response to cold, brown fat is activated through sympathetic
signalling. Norepinephrine activates β3-adrenergic receptors on the
brown adipocytes, initiating lipolysis of the intracellular triglyceride
storage. Free fatty acids are released as substrate, triggering mitochon-
drial respiration, which generates a mitochondrial membrane potential.
However, instead of producing ATP, the mitochondrial membrane
potential is uncoupled through the brown fat speciﬁc protein:
Mitochondrial brown fat uncoupling protein 1 (UCP1), resulting in
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dissipation of the energy as heat [6]. Thus, through this mechanism
brown fat consumes energy and has thereby become an attractive target
in the battle against obesity, and novel avenues to increase this process
are now being intensively investigated. Importantly, mitochondrial
uncoupling capacity has been reported to be comparable between mice
and humans [15], suggesting that the major species diﬀerence might be
due to a higher ratio of inactive cells per active brown adipocyte in
humans, resulting in a lower abundance of activated mitochondria and
ultimately a weaker response than observed in mice. This argue against
the proposition that human brown fat is beige [16] or a mixture of
classical brown and brite [7]. Rather, this might indicate heterogeneity
in the amount and grade of activation of the human brown adipocytes.
So why would mice have more activated brown adipocytes? One aspect
is that brown fat needs to be induced to diﬀerentiate into active brown
fat and by living mainly at thermoneutrality, humans fail to keep this
channel open. In contrast, experimental mice are in general kept at
room temperature, which is below their thermoneutral set-point.
Indeed, it has been clearly demonstrated that metabolic response is
determined by ambient temperature [17]. Related to this point are the
diﬀerences in body size between humans and mice. As mice have a
relatively large surface in relation to body volume, they lose much more
heat than humans, who rather have developed mechanisms to waste
heat, e.g. by sweat.
In addition to norepinephrine-induced lipolysis, other factors are
important for the heat-producing machinery of brown fat. Following
NE-induced lipolysis, an increased substrate availability results in an
acceleration of the electron transport chain in the mitochondria which,
as a by-product, generate the superoxide radical (•O−). Interestingly,
an interaction between superoxides and UCP proteins have been
demonstrated [18]. In line with this observation, the levels of mito-
chondrial reactive oxygen species (ROS) is increased in activated BAT
[19]. At the same time, ROS has been shown to be beneﬁcial for
providing thermogenesis as it activates UCP1 by sulfenylation at
Cyc253 [19]. Another recent study demonstrated a mechanism in
brown fat for maintaining a healthy population of mitochondria despite
a high level of reactive oxygen stress-induction. This maintenance of
mitochondrial integrity was provided by AMPK activation upon cold-
induced thermogenesis. It was demonstrated that AMPK induces
mitophagy which is crucial for maintaining mitochondrial integrity
and thereby also the function of murine brown fat [20]. The study also
demonstrated that AMPK is activated in supraclavicular-derived human
brown fat cell strains upon norepinephrine stimulation [20], suggesting
that this mechanism is conserved between species. An additional
pathway identiﬁed as important for brown fat activation, is adenosine
signalling through the AdenosineA2A receptor. This pathway protects
mice from diet-induced obesity and plays an important role in
sympathetic BAT activation in both murine and human brown adipo-
cytes [21]. Thus, these conserved pathways might be valuable to
consider for improvement of brown fat eﬃciency in humans.
3. Activation of BAT improves insulin sensitivity
Initial reports on active BAT in adult humans demonstrated glucose
uptake in activated BAT depots using Pet/CT-Scan [1–4,22]. Since then,
sequential cold-stimulations over time have conﬁrmed initial ﬁndings
and have provided more insight into the metabolic role of brown fat in
healthy humans [23–25]. A recent study demonstrated that the main
substrate used by activated brown fat is fatty acids derived from
intracellular triglycerides [26]. However, a simultaneous uptake of
systemic non-esteriﬁed fatty acids (NEFA) [27] and glucose [23] has
been described, probably occurring to compensate for the energy loss
and for building up new triglycerides [26]. These properties make
activation of brown fat to an attractive strategy for counteracting
metabolic disease. Increased BAT activation over time, i.e. cold
acclimation, has been shown to increase glucose uptake in BAT
[23,28]. Interestingly, the amount of activated BAT increased during
winter compared to summer [4] and increased following sleeping in a
cold (19 °C) room with light clothing for a month [24], demonstrating
an ability of human BAT to adapt to the environment, as already well-
established in mice [6]. This adaptation is an important observation
strongly suggesting that brown fat has a role in temperature regulation
also in adult humans. Moreover, several cold acclimation protocols
have, along with increased BAT activation, also demonstrated an
improved insulin sensitivity [23,24,29]. The molecular mechanisms
for this increased insulin sensitivity is not known but might be related
to an increased amount of BAT following cold acclimation. The role of
human brown fat in regulating glucose levels was further emphasized
by another study, suggesting that human BAT activity have a role in
buﬀering glucose ﬂuctuations [30], and raising the idea that human
BAT activity is under circadian control as has been clearly demon-
strated with murine BAT activity, which is regulated by Rev-Erbα [31].
In fact, even people suﬀering from obesity [32] and type 2 diabetes
[29] experienced an increased insulin sensitivity following a sequential
cold stimulation protocol, while BAT volume was associated with
adipose tissue insulin sensitivity in a cohort of over-weight and obese
subjects [33]. Hence, a role in regulating glucose metabolism of BAT in
adult humans is established. Moreover, a pharmacological study using
the β3-agonist, mirabegron demonstrated an increased resting meta-
bolic rate with 203±40 kcal/day, mediated by the increased activa-
tion of human BAT [34]. In contrast, none of the cold acclimation
studies performed in humans have to date demonstrated any loss of
total body weight. Although body fat mass has been demonstrated to
decrease [35], the total body weight is maintained, also in obese
individuals. This is somewhat surprising considering the established
negative correlation in the initial studies between BAT activity and
obesity [2,4]. This consistent lack of weight loss in response to
increased BAT activation, despite an increased metabolic rate, might
be due to the extent and the limited duration of the interventions.
However, it cannot be excluded that a compensatory energy intake is
induced to preserve the individual body weight set-point. Whether this
potential cross-talk exist and how it is regulated remains to be explored.
4. The potential role of batokines in BAT recruitment and
metabolism
Cypess and colleagues characterized several levels of brown fat in
the neck area and described a core of brown fat which gradually turned
into a less pronounced brown fat phenotype in the superﬁcial regions
[9]. The precise mechanisms by which the presence or activation grade
of human brown fat is determined are currently not well described.
Secreted factors from BAT, i.e. batokines might be involved in regulat-
ing this process in an autocrine or paracrine manner. Batokines secreted
from brown or beige fat represent a so far unexplored ﬁeld in humans,
but has recently caught increased interest and are better described in
rodent models which has been nicely been reviewed [14]. For example,
members of the bone-morphogenetic proteins have been described to be
involved in the diﬀerentiation of adipocytes, where BMP7 regulates
brown adipogenesis while BMP4 has been described to target beige
adipogenesis [14]. Another interesting batokine is VEGFA which targets
endothelial cells to induce vascularization of BAT [36]. Knockout of
VEGFA resulted in a “whitening” of murine brown fat depots [37],
emphasizing the importance of vascularization for maintaining a brown
fat phenotype. Interestingly, pro-angiogenic factors was also demon-
strated to induce proliferation of human beige adipocyte progenitors in
association with expanding capillary networks [38]. It is well-estab-
lished that white fat communicates with other organs by secreting
adipokines, e.g. leptin [39] and adiponectin [40], which contributes to
the regulation of whole body energetics. The fat-induced secretion of
leptin from white adipocytes, rasie the idea that corresponding brown
fat derived adipokines could be involved in regulating appetite and
whole body metabolism. Indeed, a beige fat derived Slit-2C fragment
was described in vivo in mice to enhance non-shivering thermogenesis,
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resulting in increased energy expenditure and improved glucose home-
ostasis h [41]. Hence, identifying and determine the function of
potential human batokines might thus lead to the discovery of novel
drug targets against obesity.
5. Browning of human visceral fat
Cold acclimation protocols in humans have not revealed any
inducible brown fat depots in addition to the constitutively present
depots, i.e. the neck, supraclavicular, spinal cord and perirenal depots.
This is in sharp contrast to mice where cold-induction of a brown fat
phenotype called beige [42] is observed in the subcutaneous inguinal
white fat depot [42]. The phenomenon was initially demonstrated in
vitro under stimulation of PPARγ in epidydimal adipocytes which were
named brite [43]. The brite/beige fat also express UCP1, is induced
during cold acclimation and has an increased energy consumption
while providing non-shivering thermogenesis [42,43]. Interestingly, a
compensatory browning can occur in the white fat of mice, following
ablation of the classical brown fat, supporting the idea that beige and
brown fat progenitors are of diﬀerential origin but can provide similar
functional phenotypes [44]. Although cold challenges have not proven
enough to mediate browning of white fat depots of humans, cases of
chronically elevated sympathetic activation, has been reported to
produce brown fat morphology and function in human white fat
(Fig. 1). For example, browning of white fat depots in adult humans
have been observed in patients suﬀering from the catecholamine
producing adrenal gland tumor, called pheochromocytoma. Interest-
ingly, the pheochromocytoma-induced brown fat phenotype is not
equally distributed among the white fat depots, but is selectively
occurring in the visceral fat depots, including the perirenal region
and even the omental fat depot [45,46]. In a case study, a pheochro-
mocytoma patient was PET/CT-scanned at diagnosis, following α-
blockade and following removal of the tumor [47]. This subject had
dramatic levels of glucose uptake during PET/CT-scanning in the
abdominal visceral fat, strongly suggesting brown fat activity. This
glucose uptake was reduced upon α-blockade and disappeared follow-
ing removal of the norepinephrine producing tumor. Interestingly, it
has been demonstrated in a larger sample set that whereas a
pronounced browning occurs in the visceral fat, pheochromocytoma
induced browning does not occur in the subcutaneous depots [45].
Hence, a subcutaneous depot susceptible for browning in adult humans
corresponding to the murine subcutaneous inguinal depot, has not been
identiﬁed. Rather, the visceral fat, traditionally regarded as the
unhealthy fat type associating with insulin resistance [48], seems to
be more prone to adapt a brown fat phenotype in humans. This could be
related to the proximity to the adrenal gland tumor, but would likely
also relate to the higher vascularity of visceral fat, as this has been
demonstrated as an important factor in determining brown versus white
fat cell destiny [37]. In addition to the visceral fat depots, BAT activity
in the brown fat regions including supraclavicular, deep neck and
intercostal depots, is heavily increasing, suggesting brown fat biogen-
esis or increase in the amount of active brown fat. Although the
browning source is originating from the adrenal gland, these data could
be considered as an indicatory map of the human fat regions that are
brown fat
demonstrated in humans
demonstrated in mice
subcutaneous white fat
visceral white fat
cold
meal
aging
circadian
rhythm
exercise
healthy physiology
disease/injury
healthy physiology
disease/injury
cancer-induced
cachexia
burn injury
pheochromocytoma
Fig. 1. Regulation of human brown fat and induction of white fat browning. Several physiological conditions have been demonstrated to inﬂuence brown fat activity in humans. When
present in human adults, cold activates the brown fat depots which mainly are present at the cervical, supraclavicular and paravertebral areas and sometimes also in the perirenal region.
Brown fat is also induced in response to a meal and is activated in a circadian manner in mice and seems to have a biorhythm with an opposing pattern to plasma glucose in humans.
Aging is negatively associated with the appearance of active brown fat. In terms of browning of white fat depots, physical exercise has been shown in mice to induce browning of
subcutaneous inguinal fat; however, this has not been reproducible in subcutaneous fat humans. In contrast, pheochromocytoma, a catecholamine-producing tumor in the adrenal gland,
has a well-described browning eﬀect on the visceral fat depots, including the perirenal, omental and mesenteric fat, while no eﬀect has been observed on subcutaneous depots. Burn
injury, on the other hand, demonstrated a gradually increasing brown fat phenotype in the subcutaneous fat following severe burn injury in a mixed cohort of children and adults. The
severe burn injuries were associated with chronically elevated levels of norepinephrine. Another disease related browning eﬀect has been observed in cancer cachexic mice were
accelerated lipolysis as well as browning was shown to occur in the white fat depots. A tumor-derived factor, PTHrP, was shown to induce this phenotype and was shown to be higher in
tumor patients with more severe cachexia. Whether the mechanism of cancer cachexia induced browning occur in humans and which depot is targeted, remains to be investigated.
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susceptible for sympathetically induced diﬀerentiation into mature
brown fat. Notably, a brown fat morphology deﬁned from autopsy
biopsies, has been found in children in several visceral fat regions,
including the mesenteric and omental depot, whereas subcutaneous fat
was reported to almost completely lack brown fat morphology [49].
Although the only active brown fat depot in the visceral region detected
in healthy adult humans is represented by the perirenal fat, these
observations raise the possibility that brown or beige fat progenitor
cells are still present in additional visceral depots [46,47,49].
6. Browning of human subcutaneous fat
In one recent study, browning was observed in the subcutaneous
depot in response to severe burn injury [50]. However, human
subcutaneous tissue has not been shown to demonstrate brown fat
even in early childhood [49] and despite elevated systemic levels of
norepinephrine, the mechanism for burn-injury induced browning,
which is a complex condition, including immune system mobilization
and tissue repair, might therefore be completely separate from the
pheochromocytoma-induced browning. In either case, an increase in
activated brown fat mass, i.e. browning, can occur in humans, induced
through sympathetic activation and norepinephrine release. Whether
this browning is induced directly by norepinephrine or mediated by
secondary factors previously described in murine or cell based studies
[51] remains to be investigated. Another condition where browning
have been reported to occur in mice is physical exercise [52,53]. In
humans, however, browning genes have not been shown to change in
adipose tissue biopsies [54]. One problem with studying humans is the
diﬃculties of accessing adipose tissue samples in the deeper fat regions.
For example, investigating the visceral fat depots for browning follow-
ing physical exercise would be of great interest, but has to date not been
performed, due to the high-risk properties involved in such clinical
procedure. Thus, the easy-accessible depot through biopsy sampling is
the subcutaneous fat depot- a depot in humans where browning might
not occur in other conditions than severe burn injury [50]. Finally,
browning has been shown to occur in mice in relation to cancer
cachexia [55,56]. Cancer cachexia is characterized by massive weight
loss and is a severe complication in patients suﬀering from a subgroup
of cancers including lung cancer. Browning of white fat as well as
increased activation of brown fat has been suggested to be part of the
energy wasting mechanism. Interestingly, although not yet demon-
strated in humans, it was found that a certain factor, PTH was secreted
from the cancer tumor and induced browning. In humans, this factor
associated with severity of cachexia, indicating also a role of the PTH in
human lung cancer induced cachexia. Whether exercise and cancer
cachexia induce browning of white subcutaneous fat in humans thus
remains to be further investigated.
7. The appearance of brown fat throughout the aging continuum
of humans
Human BAT seems to gradually decline with age as only 14% of
humans over 40 years old have been estimated to have cold activated
BAT [4,57,58]. Thus, it could be discussed whether middle-aged and
older people might have a too small amount of BAT to beneﬁt from
activation. On the other hand, current methods for in vivo BAT
quantiﬁcations are limited to detection of activated BAT, and the actual
abundance and frequency of the tissue might be underestimated.
Autopsy studies of infants and children under the age of 10 have
demonstrated presence of multilocular brown fat morphology in multi-
ple fat regions [49]. One early hypothesis which deserves to be
mentioned is that the thermogenic regulation is immature and in excess
in children, whereas it stabilizes in adults [49]. Revisiting this thought,
this would suggest a physiological capacity of adapting to the environ-
mental conditions of the growing child. Thus, a life-long lack of
thermogenic demands in humans could possibly explain the age-
associated decline in proportional amount of brown fat [4,57,58]. In
postmortem samples collected from adult humans, a multilocular
brown fat morphology was restricted to deeper fat regions close to
the vascular structures, consistent with more recent ﬁndings were tissue
gene expression also was validated [7–9]. The BAT location in adults
support the idea that thermoregulation is provided to the thoracic
structures and cervical spinal regions as a “thermogenic jacket” [49].
The age-related abundance observed in the early studies of postmortem
samples are consistent with recent reports on cold-induced BAT in
humans detected by using PET/CT-Scan technology [4,35,49]. Collec-
tively, data indicates that the amount of active brown fat as well as
multilocular morphology, declines with age in terms of amount and
frequency and is at an adult stage, i.e. age over 40 years old, restricted
to the area around neck vessels, intercostal vessels, para-aortic region
and the perirenal depot. Visceral fat developed multilocular UCP1-
expressing fat structures in pheochromocytoma patients, while the
subcutaneous fat was not aﬀected [45,46]. This express the possibility
that immature brown fat progenitor cells still exist in adults in regions
where BAT was active during early childhood. A presence of quiescent
progenitor cells distributed predominantly in the human visceral fat
could explain the massive browning occurring in this depot rather in
the subcutaneous region.
8. Human brown fat progenitor cells
It has been described that preadipocytes derived from the stromal
vascular fraction of human supraclavicular brown fat establish a brown
fat phenotype when diﬀerentiated in vitro, despite using the same
diﬀerentiation protocol as used for subcutaneous white preadipocytes
[7]. These results suggest an intrinsic diﬀerence between preadipocytes
derived from human brown fat depots compared to white fat depots. It
was further demonstrated that these cells expressed markers for
classical brown fat, but were also positive for some markers previously
described in mice as beige fat markers [16]. This observation empha-
sizes the heterogeneous status of human BAT which is frequently
reported in tissue [7]. Subsequent eﬀorts to characterize human brown
adipocytes have been made. A study from the Tseng laboratory
generated 128 brown and 152 white fat clones from human neck
biopsies of 4 subjects [59]. The authors succeeded in identifying a cell
surface marker speciﬁcally present in the brown fat progenitor cells,
CD29, and predicting UCP1 response in the mature adipocytes. They
further reported great variability in terms of brown fat cell identity,
even between clones derived from the same starting cell strain. Thus, it
was conﬁrmed that human brown fat progenitor cells have a unique
expression proﬁle compared to white fat progenitor cells and that
human brown fat cell cultures are heterogeneous –even within the same
cell strain, isolated from the same biopsy. This observation should be
considered when interpreting the results of another recent study. Here
only two clones derived from supraclavicular human brown fat were
compared to mice brown and beige fat, at a transcriptome level [60].
Interestingly, based on a subset of genes, the human clones seemed to
resemble murine beige adipocytes more than murine brown adipocytes.
Importantly, the amount of human clonal adipocyte cultures (n=2)
cannot be considered suﬃcient to exclude that adipocytes with closer
proximity to the murine classical brown also existed in the cell pool,
albeit not selected during the cloning process. Furthermore, both
studies mentioned above utilize immortalized cell cultures. The im-
mortalization per se could inﬂuence cell metabolism and cell fate [61]
and there could be a selection occurring for the cell type which more
easily can survive the immortalization process. Whether the hetero-
geneity of human brown fat consist of a mixture of classical brown and
beige adipocytes or whether it consists of brown preadipocytes at
diﬀerent stages on its way to ﬁnal determination currently remains
elusive. To completely entangle and classify human fat, lineage tracing
should be performed, i.e. tracking back the cell population to a single
cell origin. In rodents, brown fat progenitors have been described to
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have a common Myf5+ progenitor cell with skeletal muscle [62–64]. In
humans, traditional lineage tracing is not feasible. However, the new
generation of single cell transcriptomics is rapidly evolving and could
be applied on isolated fat progenitor cells from diﬀerent fat depots. This
would allow for grouping into homogenous groups for clarifying
diﬀerences between these groups in terms of stages of pre-programmed
brown fat gene signatures.
9. Perspectives and concluding remarks
Using BAT for mediating weight loss in humans might demand other
strategies than sequential BAT activation through cold exposure. This
could include identifying pathways for programming and inducing
diﬀerentiation of brown fat progenitor cells to increase brown fat
biogenesis. To fully understand the transcriptional programme of
human browning, a transcriptional map at single cell level across
depots will be useful. A research area with great potential is represented
by secreted brown fat adipokines, i.e. batokines, which might inﬂuence
brown fat biogenesis, but might also regulate appetite or energy
expenditure. Finally, eﬀorts should focus on identiﬁcation and neutra-
lisation of BAT induced energy-saving negative feedback circuits. In
conclusion, unravelling the molecular means of increasing BAT activity
in adult humans have a great potential in the search for novel strategies
to combat obesity and its related diseases.
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